114903-05-8
- Product Name：a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2
- Molecular Formula：C81H91N7O27
- Purity：99%
- Molecular Weight：1594.62
Product Details;
CasNo： 114903-05-8
Molecular Formula： C81H91N7O27
Quality Factory Sells Top Purity 99% a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2 114903-05-8 with Safe Delivery
- Molecular Formula:C81H91N7O27
- Molecular Weight:1594.62
- PSA：461.26000
- LogP:6.12762
114903-05-8 Relevant articles
Formal Synthesis of Anticoagulant Drug Fondaparinux Sodium
Dai, Xiang,Liu, Wentao,Zhou, Qilong,Cheng, Chunwei,Yang, Chao,Wang, Shuqing,Zhang, Min,Tang, Pei,Song, Hao,Zhang, Dan,Qin, Yong
, p. 162 - 184 (2016)
The practical formal synthesis of the an...
New process method for preparing fondaparinux sodium
-
Paragraph 0041; 0042, (2018/07/15)
The invention discloses a new process me...
A pentose compound of intermediate and its preparation method
-
Paragraph 0088-0090; 0104; 0114, (2018/06/21)
The invention relates to an intermediate...
the sulphur reaches the liver last of the ten Heavenly Stems sodium and intermediate thereof, and preparation method
-
Paragraph 0068; 0103; 0107; 0110, (2017/08/25)
The invention relates to fondaparinux so...
PROCESS FOR THE PRODUCTION OF FONDAPARINUX SODIUM
-
Paragraph 0124-0126, (2017/02/24)
The present invention refers to a fly st...
114903-05-8 Process route
-
-
C98H107N7O32
-
-
114903-05-8
methyl O-(2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1→4)-O-(2,3-di-O-benzyl-β-D-glucopyranosyl uronic acid)-(1→4)-O-(2-azido-2-deoxy-α-D-glucopyranosyl)-(1→4)-O-(3-O-benzyl-α-L-idopyranosyluronic acid)-(1→4)-2-benzyloxy carbonylamino-3-benzyl-2-deoxy-α-D-glucopyranoside
| Conditions | Yield |
|---|---|
|
With
water; dihydrogen peroxide; sodium hydroxide;
In
tetrahydrofuran;
at 10 - 30 ℃;
for 48h;
Inert atmosphere;
|
82% |
|
With
dihydrogen peroxide; sodium hydroxide;
In
tetrahydrofuran; water;
at 10 - 40 ℃;
for 48h;
Inert atmosphere;
|
82% |
|
With
water; dihydrogen peroxide; sodium hydroxide;
In
tetrahydrofuran;
at 10 - 30 ℃;
for 48h;
Inert atmosphere;
|
82% |
|
With
water; dihydrogen peroxide; sodium hydroxide;
In
tetrahydrofuran;
at 10 - 30 ℃;
for 48h;
Inert atmosphere;
|
82% |
|
With
dihydrogen peroxide; sodium hydroxide;
In
tetrahydrofuran; water;
at 10 - 40 ℃;
for 48h;
Inert atmosphere;
|
82% |
|
With
water; sodium hydroxide;
In
methanol;
at 20 ℃;
for 2h;
Temperature;
|
11 g |
-
-
C93H105N7O32
-
-
114903-05-8
methyl O-(2-azido-3,4-di-O-benzyl-2-deoxy-α-D-glucopyranosyl)-(1→4)-O-(2,3-di-O-benzyl-β-D-glucopyranosyl uronic acid)-(1→4)-O-(2-azido-2-deoxy-α-D-glucopyranosyl)-(1→4)-O-(3-O-benzyl-α-L-idopyranosyluronic acid)-(1→4)-2-benzyloxy carbonylamino-3-benzyl-2-deoxy-α-D-glucopyranoside
| Conditions | Yield |
|---|---|
|
With
water; sodium hydroxide;
In
tetrahydrofuran;
at 0 - 25 ℃;
|
98.4% |
|
C93H105N7O32;
With
water; lithium hydroxide;
In
tetrahydrofuran;
at 20 ℃;
for 16h;
With
water; sodium hydroxide;
In
tetrahydrofuran; methanol;
for 24h;
With
hydrogenchloride;
In
tetrahydrofuran; methanol; water;
|
89% |
|
With
sodium hydroxide;
In
methanol; chloroform; water;
for 6h;
|
72% |
|
With
water; sodium hydroxide;
In
methanol;
at 20 ℃;
for 2h;
|
Relevant Products
-
Atosiban AcetateCAS：90779-69-4
-
GABACAS：56-12-2
-
Fondaparinux sodiumCAS：114870-03-0
